FDA Approves Opdivo (Nivolumab) for Small Cell Lung Cancer
The US Food and Drug Administration had approved the immunotherapy drug Opdivo (nivolumab) to treat people with small cell lung cancer (SCLC).
Cancer Patients Want More Information From Doctors About Cost
A study led by researchers from University of Michigan has found that many cancer patients would like more help from their health care providers in addressing costs of treatment.
FDA Approves Poteligeo (Mogamulizumab) for Lymphoma of the Skin
The US Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab) to treat people with some types of skin lymphoma.
FDA Approves Azedra (Iobenguane) for Rare Adrenal Tumors
The US Food and Drug Administration has approved the radiotherapy drug Azedra (iobenguane I-131) to treat some adults and adolescents ages 12 and older with rare tumors of the adrenal gland called pheochromocytomas, as well as for similar tumors outside of the adrenals, called paragangliomas.
‘Incidental’ Imaging Findings Unlikely to be Cancer
Researchers from University of Oxford and Stanford University have reviewed hundreds of studies to learn how often incidental abnormal findings from imaging tests are found, how often those turn out to be malignant tumors, and how often they turn out to be harmless.